Greg Neely

Professor Greg Neely, a leading researcher in Functional Genomics at The University of Sydney's School of Life and Environmental Sciences, investigates age-related neurological diseases and pain mechanisms. His work bridges human genomics with functional validation in Drosophila and mammalian systems, focusing on drug target identification and environmental interactions.

• Member, Charles Perkins Centre
• Member, Centre for Drug Discovery Innovation

Research Interests:

• Functional Annotation of Disease Genes
• CRISPR-based Drug Mechanism Discovery
• Neurodegeneration and Lifespan Extension
• Gene-Environment Interactions in Disease

Publication Trends (2025–2021): Analysis reveals emphasis on CRISPR screening (n=5), pain/neurodegeneration studies (n=8), metabolic regulation (n=6), and venom/drug discovery (n=4), with cross-species validation from Drosophila to human stem cells.

Scientific Awards:

• 2011–2016: NHMRC Marshall & Warren Award and Career Development Fellowships

Advising: Supervises honors/PhD students in projects spanning pain genetics, CRISPR screening, and longevity pathways.